News – Page 98 – Endpoints News

Pfizer targeted by activist, following post-pandemic stumbles — reports

8 months ago

WuXi companies consider sale of units impacted by Biosecure; J&J, Bayer trim staff; Ron Renaud’s latest biotech; ...

8 months ago

BARDA doles out $72M to Sanofi, GSK and CSL for bird flu vaccine supply

8 months ago

EMA reviews hair loss products following concerns about suicidal thoughts

8 months ago

RSV vaccines off to a sluggish start in US this season, with volumes behind 2023

8 months ago

Alnylam agrees to drop patent lawsuit against Moderna over Covid-19 vaccine

8 months ago

J&J discontinues mid-stage dengue study, citing deprioritization of communicable disease work

8 months ago

Editas sells future CRISPR license fees; Plus, news about Oncolytics Biotech

8 months ago

Biotech's third quarter was relatively bright — with a few caveats

8 months ago

Sanofi sells rare disease drug Enjaymo to Recordati for $825M upfront

8 months ago

After $14B exit, Karuna co-founder finds next bet; Ex-Regenxbio CEO Ken Mills heads to Tagworks

8 months ago

End of obesity drug shortage threatens patient access to compounded shots that Lilly calls risky

8 months ago

UK government proposes phased rollout of Eli Lilly's weight loss drug

8 months ago

Exclusive: Relay Therapeutics cuts another 10% of company, citing continued streamlining efforts

8 months ago

WuXi companies may sell units impacted by Biosecure — report

8 months ago

FDA's drug center launches new coordinating body for modeling and simulation

8 months ago

Novo and Lilly outline plans to mitigate disruptions from US port strikes

8 months ago

Opdivo gets FDA approval for use around lung cancer surgery, following Keytruda and Imfinzi

8 months ago

Pfizer lays off staff in Ireland; Baxter closes NC facility due to hurricane damage

8 months ago

Flagship partners with key Singapore R&D agency as it boosts APAC investment

8 months ago

FDA lifts partial hold on Avidity’s myotonic dystrophy drug; Orum's IPO in South Korea

8 months ago

Eli Lilly resolves shortage for tirzepatide, potentially ending compounders' run

8 months ago

Enara Bio’s $32.5M Series B to support lead dark antigen program for GI cancers

8 months ago

Investor Kurma Partners raises €140M for latest Europe-focused biotech fund

8 months ago

First page Previous page 95 96 979899 100 101 Next page Last page